InvestorsObserver
×
News Home

What is the Market's View on VBI Vaccines Inc (VBIV) Stock's Price and Volume Trends Monday?

Monday, August 08, 2022 10:20 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on VBI Vaccines Inc (VBIV) Stock's Price and Volume Trends Monday?

The market has been high on VBI Vaccines Inc (VBIV) stock recently. VBIV gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
VBI Vaccines Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VBIV!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With VBIV Stock Today?

VBI Vaccines Inc (VBIV) stock is trading at $1.07 as of 10:20 AM on Monday, Aug 8, an increase of $0.01, or 0.94% from the previous closing price of $1.06. The stock has traded between $0.90 and $1.08 so far today. Volume today is less active than usual. So far 771,814 shares have traded compared to average volume of 1,497,855 shares. To see InvestorsObserver's Sentiment Score for VBI Vaccines Inc click here.

More About VBI Vaccines Inc

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. Click Here to get the full Stock Report for VBI Vaccines Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App